Vascular Biology |
BDependent Transcriptional Activation of Inducible NO Synthase
From the Department of Endocrinology and Metabolism, Dokkyo University School of Medicine, Mibu, Tochigi, Japan.
Correspondence to Dr Yoshiyuki Hattori, Department of Endocrinology and Metabolism, Dokkyo University School of Medicine, Mibu, Tochigi 321-0293, Japan. E-mail yhattori{at}dokkyomed.ac.jp
AbstractThe
role of lipid peroxidation products in atherogenesis was studied.
We investigated whether 4-hydroxy-2-nonenal (HNE) modulates
activation of the nuclear factor (NF)-
B system or alters expression
of the NF-
B target gene product, inducible NO synthase (iNOS),
in vascular smooth muscle cells (VSMCs) stimulated by
lipopolysaccharide (LPS) in combination with interferon
(IFN)-
(LPS/IFN). NO production induced by LPS/IFN was
dose-dependently inhibited by HNE. NF-
B activation by LPS/IFN was
inhibited by HNE in a dose-dependent manner. HNE significantly
decreased LPS/IFN-stimulated proteolysis of I
B-
. iNOS promoter
activity stimulated by LPS/IFN was also decreased by HNE
dose-dependently. The treatment of VSMCs with LPS/IFN strongly
stimulated iNOS mRNA and protein expression. The LPS/IFN-induced
increases in iNOS mRNA and protein levels were dose-dependently
decreased by HNE. Our data suggest that treatment with HNE blocks
signaling events required for I
B-
degradation, thereby preventing
NF-
B activation. Inhibition of NF-
Bregulated gene expression,
especially modulation of NO production, may contribute to
atherogenesis.
Key Words: 4-hydroxy-2-nonenal nuclear factor-
B nitric oxide vascular smooth muscle cells
This article has been cited by other articles:
![]() |
T. Ando, K. Mimura, C. C. Johansson, M. G. Hanson, D. Mougiakakos, C. Larsson, T. Martins da Palma, D. Sakurai, H. Norell, M. Li, et al. Transduction with the Antioxidant Enzyme Catalase Protects Human T Cells against Oxidative Stress J. Immunol., December 15, 2008; 181(12): 8382 - 8390. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. N. Churchill, M.-H. Disatnik, G. R. Budas, and D. Mochly-Rosen Ethanol for cardiac ischemia: the role of protein kinase c Therapeutic Advances in Cardiovascular Disease, December 1, 2008; 2(6): 469 - 483. [Abstract] [PDF] |
||||
![]() |
J. Delgado Alves, L. J. Mason, P. R. J. Ames, P. P. Chen, J. Rauch, J. S. Levine, R. Subang, and D. A. Isenberg Antiphospholipid antibodies are associated with enhanced oxidative stress, decreased plasma nitric oxide and paraoxonase activity in an experimental mouse model Rheumatology, October 1, 2005; 44(10): 1238 - 1244. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Monaco and E. Paleolog Nuclear factor {kappa}B: a potential therapeutic target in atherosclerosis and thrombosis Cardiovasc Res, March 1, 2004; 61(4): 671 - 682. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |